Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709 by Ekinci, Elif I. et al.
COMMENTS AND
RESPONSES
Response to
Comment on:
Ekinci et al. Dietary
Salt Intake and
Mortality in Patients
With Type 2
Diabetes. Diabetes
Care 2011;34:
703–709
W
e thank Lambers Heerspink et al.
(1) for their comments and agree
that observational studies are
prone to confounding. We also agree that
our study population represents high-risk
patientswithadvancedtype2diabetesand
does not represent the general population.
Importantly, after adjusting for factors in-
dependently associated with all-cause
mortality including age, sex, duration of
diabetes, atrial ﬁbrillation, the presence
and severity of chronic kidney disease (es-
timated glomerular ﬁltration rate and log
albumin excretion rate), and parameters
associated with 24-h urinary sodium ex-
cretion(24hUNa)includingBMI,all-cause
mortality remained inversely associated
with 24hUNa such that individuals
with a lower 24hUNa had a higher cumu-
lative hazard for mortality. Furthermore,
the mean systolic blood pressure (sBP) in
each tertile of 24hUNa was very similar,
i.e., 141 6 17 mmHg (Tertile 1, 24hUNa
,150mmol);1406 17 mmHg (Tertile 2,
24hUNa:150–208 mmol); and 140 6 16
mmHg (Tertile 3, 24hUNa .208 mmol).
These levels approximate mean achieved
sBP in the control groups of two recent
studies in high-risk patients with type 2
diabetes. Neither cardiovascular events
in the Action to Control Cardiovascular
Risk in Diabetes (ACCORD) study (2)
nor total mortality in the International
Verapamil-Trandolapril (INVEST) study
(3) were reduced by intensive blood pres-
sure control.
Lambers Heerspink et al. also question
whether the renin-angiotensin system
could be activated in the range of 24hUNa
reported in our study. In a subgroup of
patients drawn from the same population
reported in our study, we have previously
shown that habitual low dietary salt intake
(24hUNa:118 6 12 mmol) is associated
with a signiﬁcantly increased plasma renin
activity when compared with a habitual
high dietary salt intake group (24hUNa:
271 6 24 mmol) (4). Furthermore, high
plasma renin activity was an independent
predictorofmajorvasculareventsandmor-
tality in the Heart Outcomes Prevention
Evaluation (HOPE) study (5).
Wehavealsopreviouslyshownfavor-
ableshort-termeffectsofalowsaltdieton
blood pressure and albuminuria in pa-
tients with type 2 diabetes (4). However,
the recent long-term study in patients
with type 1 diabetes has shown that there
is a steep increase in mortality when uri-
nary sodium excretion is ,100 mmol/
24 h, and there is an inverse relationship
between 24hUNa and the incidence of
end-stage renal disease (6).
Insupportofourdata,arecentlypub-
lished community-based longitudinal
study (7) has shown that despite sBP be-
ing aligned with changes in 24hUNa, this
did not translate into higher risk of car-
diovascular disease end points. Lower
24hUNa was associated with higher car-
diovascular disease mortality.
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